CN116283827A - Preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof - Google Patents

Preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof Download PDF

Info

Publication number
CN116283827A
CN116283827A CN202310171234.1A CN202310171234A CN116283827A CN 116283827 A CN116283827 A CN 116283827A CN 202310171234 A CN202310171234 A CN 202310171234A CN 116283827 A CN116283827 A CN 116283827A
Authority
CN
China
Prior art keywords
formula
compound
catalyst
oxidant
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310171234.1A
Other languages
Chinese (zh)
Inventor
袁建勇
马婉倩
匡秋林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chongqing Medical University
Original Assignee
Chongqing Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chongqing Medical University filed Critical Chongqing Medical University
Priority to CN202310171234.1A priority Critical patent/CN116283827A/en
Publication of CN116283827A publication Critical patent/CN116283827A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/68Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82Nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Catalysts (AREA)

Abstract

The invention provides a preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof, which is characterized in that FeCl 3 And in the presence of TBHP, the oxidative coupling reaction of aldehyde and 2-aminobenzothiazole is smoothly carried out, so that the corresponding product is generated, and the yield is good.

Description

Preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof
Technical Field
The invention relates to pharmaceutical chemistry, in particular to a preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof.
Background
Functionalized 2-aminobenzothiazoles are an important class of heterocycles that exist in many biologically active natural products and drugs. Such as riluzole (P.Jimonet, F.Audiau, M.Barreau, J.Med.Chem.1999,42,2828) for use in the treatment of Amyotrophic Lateral Sclerosis (ALS). 2-aminobenzothiazoles replace the inner ring nitrogen with potential biological properties. In functionalized N-acyl 2-aminobenzothiazoles, the 4-methoxybenzamide derivative is an inhibitor of 17- β -hydroxysteroid dehydrogenase 1 (R.Hartmann, M.Frotscher, S.Marchais-Oberwinkler, PCT Int. Appl., WO 2012025638,Mar 1,2012.).
Because of the wide range of biological properties exhibited by such compounds, the development of a simple and easy-to-implement 2-aminobenzothiazole functional synthesis strategy has attracted considerable attention from organic chemists. The traditional synthetic method for N-acyl 2-aminobenzothiazoles is the reaction of 2-aminobenzothiazoles with the corresponding carboxylic acid/derivative (r.m. de Figueiredo, j. -s.supplo and j. -M.Campagne, chem.Rev.,2016,116.). In most cases, this process requires coupling reagents and produces stoichiometric by-products.
Main content
The invention aims to provide a preparation method of N-acyl 2-aminobenzothiazole and derivatives (formula III) thereof.
In order to achieve the above purpose, the technical scheme of the invention is as follows:
the preparation method of the N-acyl 2-aminobenzothiazole and the derivatives thereof is prepared by reacting a compound shown in a formula I with a compound shown in a formula II under the action of a catalyst and an oxidant, and the synthetic route is as follows:
Figure BDA0004099050300000011
wherein R is H, one or more C 1-6 Alkyl or cycloalkyl, one or more OC 1-6 Alkoxy, phenyl, nitro, one or more halogens or one or more halogen substituted halogenated C 1-6 An alkyl group.
The catalyst is selected from CuI and CuCl 2 、FeCl 3 、NiCl 2 One or a combination of a plurality of the above;
the oxidant is selected from TBHP, H 2 O 2 One or more of DTBP and TEMPO.
Further, in the above method, the catalyst is selected from CuCl 2 、FeCl 3 、NiCl 2 One or a combination of more than one of the above, wherein the oxidant is selected from TBHP.
Further, in the above method, the catalyst is selected from FeCl 3 The oxidizing agent is selected from TBHP.
Further, in the above method, the catalyst is used in an amount of 0.1 to 0.2mol%.
Further, in the above method, the amount of the oxidizing agent is 1 to 4 equivalents.
Further, in the above method, the compound of formula II is used in an amount of 1 to 2 equivalents.
Further, in the above method, the reaction temperature is 80 to 100 ℃.
Further, in the above method, the reaction solvent is 1, 2-dichloroethane or toluene.
The above compound of formula III is selected from the following compounds:
Figure BDA0004099050300000021
the preparation method of the compound of the formula IV-3 is characterized in that the compound of the formula IV-1 and the compound of the formula IV-2 react under the action of a catalyst and an oxidant, and the synthetic route is as follows:
Figure BDA0004099050300000022
the catalyst is selected from FeCl 3 The oxidant is selected from TBHP; the catalyst is used in an amount of 0.1-0.2mol%, the oxidant is used in an amount of 1-4 equivalents, the compound of formula IV-2 is used in an amount of 1-2 equivalents, the reaction temperature is 80-100 ℃, and the reaction solvent is 1, 2-dichloroethane or toluene.
The preparation method of the compound of the formula V-3 is characterized in that the compound of the formula V-1 and the compound of the formula V-2 react under the action of a catalyst and an oxidant, and the synthetic route is as follows:
Figure BDA0004099050300000031
the catalyst is selected from FeCl 3 The oxidant is selected from TBHP; the catalyst is used in an amount of 0.1-0.2mol%, the oxidant is used in an amount of 1-4 equivalents, the compound of formula V-2 is used in an amount of 1-2 equivalents, the reaction temperature is 80-100 ℃, and the reaction solvent is 1, 2-dichloroethane or toluene.
The preparation method of the compound of the formula VI-3 is characterized in that the compound of the formula VI-1 and the compound of the formula VI-2 react under the action of a catalyst and an oxidant, and the synthetic route is as follows:
Figure BDA0004099050300000032
the catalyst is selected from FeCl 3 The oxidant is selected from TBHP; the catalyst is used in an amount of 0.1 to 0.2mol percentThe amount of the oxidant is 1-4 equivalents, the amount of the compound of the formula VI-2 is 1-2 equivalents, the reaction temperature is 80-100 ℃, and the reaction solvent is 1, 2-dichloroethane or toluene.
The beneficial effects are that:
the invention provides a method for efficiently synthesizing N-acyl-2-aminobenzothiazole. In FeCl 3 And in the presence of TBHP, the oxidative coupling reaction of aldehyde and 2-aminobenzothiazole is smoothly carried out, so that the corresponding product is generated, and the yield is good.
Detailed Description
The present invention is described in detail below by way of specific examples, which are given herein for the purpose of further illustration only and are not to be construed as limiting the scope of the present invention, as many insubstantial modifications and variations of the present invention will become apparent to those skilled in the art in light of the foregoing disclosure. The raw materials and the reagents used in the invention are all commercial products. Except for special descriptions, the parts are parts by weight, and the percentages are mass percentages.
Example 1
Into a 25ml round bottom flask was charged 2-aminobenzothiazole 1a (0.7 mmol,1.0 equiv), benzaldehyde 2a (1.05 mmol,1.5 equiv) derivatives, TBHP (2.1 mmol,3 equiv) and FeCl 3 (0.07 mmol,0.1 equiv) in 1, 2-dichloroethane as solvent was stirred at 100deg.C for 6h. After the reaction was completed, the mixture was extracted with saturated NaCl solution and dichloromethane, and the organic layer was extracted with anhydrous Na 2 SO 4 And (5) drying. After the solvent is removed under reduced pressure, petroleum ether/ethyl acetate is used as an eluent, and the purified product is obtained through column chromatography separation.
Results and discussion
Referring to the procedure of example 1, in a preliminary experiment, benzaldehyde and 2-aminobenzothiazole were treated with CuI as a catalyst in the presence of TBHP and the progress of the reaction was monitored by TLC. However, under this condition, the yield of N-acyl-2-aminobenzothiazole was only 35% (Table 1, entry 1). The influence of other conditions on the reaction was investigated later, and FeCl can be seen from the table 3 The catalytic effect of (a) is best (Table 1, entries 2-4). The reaction was then affected by exposure to TBHP and temperature,experiments have shown that when the TBHP is 3 equivalents, the reflection is optimal when the temperature is raised to 100 ℃ (Table 1, entries 5-7). Further experiments have found that when FeCl 3 When the amount of (a) was reduced from 0.2 to 0.1 equivalents, almost the same yield was obtained (table 1, item 8). Other oxidants were then tried on this basis, and the results indicate that only TBHP can effect the synthesis of N-acyl-2-aminobenzothiazole.
TABLE 1 optimization of reaction conditions a
Figure BDA0004099050300000041
a Reaction conditions: 1a (0.7 mmol,1.0 equiv), 2a (1.05 mmol,1.5 equiv), solvent (2 ml), 6h.
b The yield was isolated.
To verify the versatility of the reaction scheme, reaction studies were performed on a variety of aldehydes under optimized reaction conditions. Containing electron donors (-CH) 3 ,-OCH 3 ) Or electron withdrawing groups (-Cl, -Br, and-NO) 2 ) Has good tolerance and provides the corresponding products in moderate to excellent yields (3 a-3 f). Under this condition, excellent yields (3 g, 3 h) can also be provided when the benzene ring is exchanged for pyridine ring and naphthalene ring. In addition, isobutyraldehyde can also participate in this reaction with a yield of 81% (3 k).
TABLE 2 substrate extension
Figure BDA0004099050300000051
It can be seen that in the present invention, in FeCl 3 And in the presence of TBHP, the oxidative coupling reaction of aldehyde and 2-aminobenzothiazole is smoothly carried out, so that the corresponding product is generated, and the yield is good.
Nuclear magnetic data
Figure BDA0004099050300000052
N-(benzo[d]thiazol-2-yl)benzamide(3a).white solid(0.160g,92%yield).
1 H NMR(600MHz,DMSO-d 6 )δ12.90(s,1H),8.18–8.13(m,2H),8.03(dd,J=7.9,1.2Hz,1H),7.80(d,J=8.0Hz,1H),7.70–7.64(m,1H),7.58(t,J=7.8Hz,2H),7.48(ddd,J=8.3,7.2,1.3Hz,1H),7.35(td,J=7.7,7.2,1.1Hz,1H). 13 C NMR(151 MHz,DMSO)δ166.40,159.20,133.35,132.37,132.01,129.12,128.80,126.66,124.17,122.22,120.91.
Figure BDA0004099050300000061
N-(benzo[d]thiazol-2-yl)-4-methylbenzamide(3ba).white solid(0.16g,87%).
1 H NMR(600 MHz,DMSO-d 6 )δ12.81(s,1H),8.09–8.05(m,2H),8.05–8.00(m,1H),7.79(d,J=8.1 Hz,1H),7.47(ddd,J=8.3,7.2,1.3 Hz,1H),7.38(d,J=8.0 Hz,2H),7.35(ddd,J=8.1,7.2,1.1 Hz,1H),2.41(s,3H). 13 C NMR(151 MHz,DMSO)δ166.16,143.69,132.03,129.68,128.84,126.62,124.10,122.18,120.88,21.58.
Figure BDA0004099050300000062
N-(benzo[d]thiazol-2-yl)-3-methylbenzamide(3bb).white solid(0.15g,84%).
1 H NMR(600 MHz,DMSO-d6)δ12.83(s,1H),8.03(dd,J=8.1,1.2 Hz,1H),8.01–7.98(m,1H),7.96(dd,J=7.4,1.7 Hz,1H),7.80(d,J=8.1 Hz,1H),7.51–7.43(m,3H),7.35(ddd,J=8.2,7.2,1.2 Hz,1H),2.41(s,3H). 13 C NMR(151 MHz,DMSO)δ166.49,159.28,138.51,133.93,132.33,131.98,129.33,129.00,126.64,125.91,124.14,122.21,120.85,21.35.
Figure BDA0004099050300000063
N-(benzo[d]thiazol-2-yl)-2-methylbenzamide(3bc).white solid(0.15g,83%).
1 H NMR(600 MHz,DMSO-d 6 )δ12.75(s,1H),8.05–8.00(m,1H),7.79(d,J=8.0Hz,1H),7.63(dt,J=7.8,1.8 Hz,1H),7.46(dddd,J=7.6,6.3,5.0,1.3 Hz,2H),7.37–7.31(m,3H),2.45(s,3H) 13 C NMR(151 MHz,DMSO)δ168.69,158.68,148.96,136.91,134.23,131.97,131.35,131.34,128.63,126.63,126.20,124.15,122.18,121.01,20.10.
Figure BDA0004099050300000064
N-(benzo[d]thiazol-2-yl)-4-methoxybenzamide(3c).white solid(0.15g,79%).
1 H NMR(600 MHz,DMSO-d 6 )δ12.72(s,1H),8.19–8.14(m,2H),8.01(d,J=7.9Hz,1H),7.78(d,J=8.1 Hz,1H),7.46(t,J=7.6 Hz,1H),7.33(t,J=7.5 Hz,1H),7.12–7.07(m,2H),3.86(s,3H). 13 C NMR(151 MHz,DMSO)δ165.63,163.41,159.42,132.03,130.92,126.58,124.35,124.02,122.14,120.78,114.43,56.02.
Figure BDA0004099050300000071
N-(benzo[d]thiazol-2-yl)-4-nitrobenzamide(3d).white solid(0.19g,95%).
1 H NMR(600 MHz,DMSO-d 6 )δ13.28(s,1H),8.39–8.34(m,4H),8.03(d,J=7.9Hz,1H),7.78(d,J=8.1 Hz,1H),7.49(ddd,J=8.2,7.2,1.3 Hz,1H),7.36(td,J=7.6,1.1 Hz,1H). 13 C NMR(151 MHz,DMSO)δ150.21,130.39,126.87,124.40,124.10,122.43.
Figure BDA0004099050300000072
N-(benzo[d]thiazol-2-yl)-4-chlorobenzamide(3e).white solid(0.18g,94%).
1 H NMR(600 MHz,DMSO-d 6 )δ12.98(s,1H),8.17–8.14(m,2H),8.04–7.99(m,1H),7.79(d,J=8.1 Hz,1H),7.67–7.61(m,2H),7.47(ddd,J=8.3,7.2,1.3 Hz,1H),7.34(td,J=7.6,7.2,1.1 Hz,1H). 13 C NMR(151 MHz,DMSO)δ138.24,131.88,130.74,129.21,126.71,124.23,122.27,120.85.
Figure BDA0004099050300000073
N-(benzo[d]thiazol-2-yl)-4-bromobenzamide(3f).white solid(0.21g,94%).
1 H NMR(600 MHz,DMSO-d 6 )δ12.99(s,1H),8.11–8.05(m,2H),8.03(dd,J=8.1,1.2 Hz,1H),7.82–7.76(m,3H),7.48(ddd,J=8.2,7.2,1.3 Hz,1H),7.35(ddd,J=8.1,7.2,1.1 Hz,1H). 13 C NMR(151 MHz,DMSO)δ132.17,130.87,127.32,126.72,124.24,122.28.
Figure BDA0004099050300000074
N-(benzo[d]thiazol-2-yl)nicotinamide(3g).white solid(0.16g,96%).
1 H NMR(600 MHz,DMSO-d 6 )δ12.21(s,1H),8.80(dd,J=4.7,1.5 Hz,1H),8.23(dt,J=7.8,1.1 Hz,1H),8.13(td,J=7.7,1.7 Hz,1H),8.06(dd,J=8.0,1.2 Hz,1H),7.83(d,J=8.0 Hz,1H),7.76(ddd,J=7.6,4.7,1.1 Hz,1H),7.49(ddd,J=8.2,7.2,1.3 Hz,1H),7.40–7.33(m,1H). 13 C NMR(151 MHz,DMSO)δ163.97,157.85,
149.53,149.07,148.25,138.79,132.21,128.43,126.76,124.40,123.66,122.33,121.31.
Figure BDA0004099050300000081
N-(benzo[d]thiazol-2-yl)-2-naphthamide(3h).white solid(0.19g,95%).
1 H NMR(600 MHz,DMSO-d 6 )δ13.04(s,1H),8.86(d,J=1.8 Hz,1H),8.18(dd,J=8.5,1.8 Hz,1H),8.12–8.06(m,2H),8.06–8.01(m,2H),7.81(d,J=8.0 Hz,1H),7.67(dddd,J=22.9,8.1,6.8,1.3 Hz,2H),7.48(ddd,J=8.3,7.2,1.3 Hz,1H),7.38–7.32(m,1H). 13 C NMR(151 MHz,DMSO)δ135.29,132.47,131.99,130.01,129.78,128.98,128.75,128.19,127.51,126.68,124.80,124.17,122.25,120.84.
Figure BDA0004099050300000082
N-(benzo[d]thiazol-2-yl)-2-methylpropanamide(3k).white solid(0.12g,81%).
1 H NMR(600 MHz,DMSO-d 6 )δ12.32(s,1H),7.98(d,J=7.9 Hz,1H),7.76–7.72(m,1H),7.44(dd,J=8.2,7.0 Hz,1H),7.30(t,J=7.6 Hz,1H),2.81(p,J=6.9 Hz,1H),1.16(d,J=6.9 Hz,6H). 13 C NMR(151 MHz,DMSO)δ176.58,158.54,149.02,131.94,126.51,123.88,122.11,120.88,34.50,19.48.。

Claims (9)

1. The preparation method of the N-acyl 2-aminobenzothiazole and the derivatives thereof (formula III) comprises the steps of reacting a compound of formula I with a compound of formula II under the action of a catalyst and an oxidant, wherein the synthetic route is as follows:
Figure FDA0004099050290000011
wherein R is H, one or more C 1-6 Alkyl or cycloalkyl, one or more OC 1-6 Alkoxy, phenyl, nitro, one or more halogens or one or more halogen substituted halogenated C 1-6 An alkyl group;
the catalyst is selected from CuI and CuCl 2 、FeCl 3 、NiCl 2 One or a combination of a plurality of the above;
the oxidant is selected from TBHP, H 2 O 2 One or more of DTBP and TEMPO.
2. The method of claim 1, wherein: the catalyst is selected from CuCl 2 、FeCl 3 、NiCl 2 One or a combination of more than one of the above, wherein the oxidant is selected from TBHP.
3. The method of claim 1, wherein: the catalyst is selected from FeCl 3 The oxidizing agent is selected from TBHP.
4. A method according to any one of claims 1-3, wherein: the catalyst is used in an amount of 0.1 to 0.2mol%; the dosage of the oxidant is 1-4 equivalents; the compound of formula II is used in an amount of 1-2 equivalents.
5. The method of claim 4, wherein: the reaction temperature is 80-100 ℃; the reaction solvent is 1, 2-dichloroethane or toluene.
6. A method according to any one of claims 1-3, wherein: the compound of formula III is selected from the following compounds:
Figure FDA0004099050290000012
7. the preparation method of the compound of the formula IV-3 is characterized in that the compound of the formula IV-1 and the compound of the formula IV-2 react under the action of a catalyst and an oxidant, and the synthetic route is as follows:
Figure FDA0004099050290000021
the catalyst is selected from FeCl 3 The oxidant is selected from TBHP; the catalyst is used in an amount of 0.1-0.2mol%, the oxidant is used in an amount of 1-4 equivalents, the compound of formula IV-2 is used in an amount of 1-2 equivalents, the reaction temperature is 80-100 ℃, and the reaction solvent is 1, 2-dichloroethane or toluene.
8. The preparation method of the compound of the formula V-3 is characterized in that the compound of the formula V-1 and the compound of the formula V-2 react under the action of a catalyst and an oxidant, and the synthetic route is as follows:
Figure FDA0004099050290000022
the catalyst is selected from FeCl 3 The oxidant is selected from TBHP; the catalyst is used in an amount of 0.1-0.2mol%, the oxidant is used in an amount of 1-4 equivalents, the compound of formula V-2 is used in an amount of 1-2 equivalents, the reaction temperature is 80-100 ℃, and the reaction solvent is 1, 2-dichloroethane or toluene.
9. The preparation method of the compound of the formula VI-3 is characterized in that the compound of the formula VI-1 and the compound of the formula VI-2 react under the action of a catalyst and an oxidant, and the synthetic route is as follows:
Figure FDA0004099050290000023
the catalyst is selected from FeCl 3 The oxidant is selected from TBHP; the catalyst is used in an amount of 0.1 to 0.2mol%, the oxidant is used in an amount of 1 to 4 equivalents, the compound of the formula VI-2 is used in an amount of 1 to 2 equivalents, the reaction temperature is 80 to 100 ℃, and the reaction solvent is 1, 2-dichloroethane or toluene.
CN202310171234.1A 2023-02-27 2023-02-27 Preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof Pending CN116283827A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310171234.1A CN116283827A (en) 2023-02-27 2023-02-27 Preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310171234.1A CN116283827A (en) 2023-02-27 2023-02-27 Preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof

Publications (1)

Publication Number Publication Date
CN116283827A true CN116283827A (en) 2023-06-23

Family

ID=86816164

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310171234.1A Pending CN116283827A (en) 2023-02-27 2023-02-27 Preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof

Country Status (1)

Country Link
CN (1) CN116283827A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108976216A (en) * 2018-09-07 2018-12-11 江苏工程职业技术学院 A kind of preparation method of prucalopride
CN114591320A (en) * 2020-12-05 2022-06-07 鲁南制药集团股份有限公司 Preparation method of zolpidem

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108976216A (en) * 2018-09-07 2018-12-11 江苏工程职业技术学院 A kind of preparation method of prucalopride
CN114591320A (en) * 2020-12-05 2022-06-07 鲁南制药集团股份有限公司 Preparation method of zolpidem

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
GUANJIE WANG,等: "Access to Amide from Aldimine via Aerobic Oxidative Carbene Catalysis and LiCl as Cooperative Lewis Acid", ORG LETT., vol. 19, no. 13, 27 June 2017 (2017-06-27), pages 3363 *
RAMESH DESHIDI,等: "Highly efficient dehydrogenative cross-coupling of aldehydes with amines and alcohols", RSC ADV., vol. 110, no. 05, 16 October 2015 (2015-10-16), pages 1 - 2 *
SETHULEKSHMY PREMALETHA,等: "Facile synthesis of N-acyl 2-aminobenzothiazoles by NHC-catalyzed direct oxidative amidation of aldehydes", CHEM COMMUN (CAMB) ., vol. 53, no. 09, 26 January 2017 (2017-01-26), pages 1478 - 1481 *
张亚静;包永胜;照日格图;: "醛与胺均相催化合成三级酰胺研究进展", 工业催化, no. 03, 15 March 2015 (2015-03-15), pages 18 - 26 *
马丽娜,等: "铁催化三级胺的氧化酰胺化反应", 第十八届全国金属有机化学学术研讨会论文摘要集, 19 August 2014 (2014-08-19), pages 319 *
龚久涵;朱正;卢林;郭生梅;蔡琥;: "铜催化的芳基酮及其衍生物氧化酰胺化合成α-酮酰胺的反应研究", 有机化学, no. 09, 30 September 2015 (2015-09-30), pages 125 - 130 *

Similar Documents

Publication Publication Date Title
Makosza et al. Hydroxylation of nitroarenes with alkyl hydroperoxide anions via vicarious nucleophilic substitution of hydrogen
EP2439193B1 (en) Derivatives of 5,6-bisaryl-2-pyridine-carboxamide, preparation and use thereof in therapeutics as antagonists of urotensin II receptors
TWI491594B (en) Process for the preparation of carboxamides
CN110028489B (en) Method for preparing benzamide compound by pressure reduction method
JPH05294954A (en) New benzopyran derivative
CN112961079B (en) Method for dehydrating primary amide into nitriles by cobalt catalysis
CN108689895B (en) A kind of thioamide derivatives and preparation method thereof
Malcolm Antitumour benzothiazoles. Part 2. Formation of 2, 2′-diaminobiphenyls from the decomposition of 2-(4-azidophenyl) benzazoles in trifluoromethanesulfonic acid
CN116283827A (en) Preparation method of N-acyl 2-aminobenzothiazole and derivatives thereof
JP2006070034A (en) Method for producing 2-aminopyridine derivative
WO2020082605A1 (en) Pyrazolyl azophenol compound and synthesis and derivation thereof
Seidel et al. Reaction of substituted 2-carbethoxyacetylaminopyridines and similar compounds with triethyl orthoformate and zinc chloride
JPH0717936A (en) Compound
KR101554539B1 (en) Development of Method for Amide Bond Formation via Metal-Free Aerobic Oxidative Amination of Aldehydes
JPH02164863A (en) Production of p-aminophenol derivative
CN109776435B (en) Method for preparing 1,2, 3-triazole by dibromovinylbenzene one-pot method
CN108558751B (en) Synthesis process of 3-nitroquinoline derivative
JP3185482B2 (en) Nitrilation method
Wang et al. A series of new polycyclic carbamoyl pyridone analogues were synthesized by using chloroacetaldehyde as a substrate
JP3873796B2 (en) 3-hydrazono-2-hydroxyiminopropionitrile derivative and process for producing the same
JPS6045626B2 (en) Novel 1,2,3,4-tetrahydronaphthalene derivative
JP4427988B2 (en) Method for producing biaryl compound
US2769012A (en) Quinone substituted phthalic acids
JP2004217542A (en) Method for producing 4,5-dialkoxycarbonylimidazole
JP4013772B2 (en) 2-Hydroxyimino-3-oxopropionitrile and process for producing the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination